Acurx Pharmaceuticals (ACXP) Tops Q4 EPS by 1c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Nvidia pitches Vera CPU to Chinese clients with August delivery target